Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2019
A New Pathway Emerges to Interpret Lung Cancer Genomic AlterationsCollin M BlakelyClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2020
Role of MPR as an Early Signal for Efficacy in Neoadjuvant StudiesCollin M Blakely, Caroline E McCoachCancer Discovery|October 17, 2012
Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistanceCollin M Blakely, Trever G BivonaExpert Review of Anticancer Therapy|December 7, 2019
Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLCCollin M Blakely, Jonathan W RiessJournal of Thoracic Disease|July 10, 2020
Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancerBeatrice Gini, Nicholas Thomas, Collin M BlakelyCurrent Oncology Reports|February 27, 2019
Emerging Targeted Therapies for the Treatment of Non-small Cell Lung CancerPatrick R Halliday, Collin M Blakely, Trever G BivonaThoracic Surgery Clinics|November 19, 2025
Neoadjuvant Tyrosine Kinase InhibitorsGavitt A Woodard, Ryan J Kramer, Collin M BlakelyCurrent Problems in Cancer|February 10, 2024
Targeting MEK in non-small cell lung cancerMatthew S Lara, Collin M Blakely, Jonathan W RiessJournal of Visualized Experiments : Jove|December 6, 2021
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived OrganoidsDora Barbosa Rabago, Collin M Blakely, Franziska Haderk, et al.Clinical Lung Cancer|July 6, 2016
Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of ResistanceCaroline E McCoach, Trever G Bivona, Collin M Blakely, et al.Pageof 6